Delivery Order SPE2DB20D1100-SPE2DB24FA8G7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SENSOREADY 150 MG PENML pharmaceutical products. The contract has an ultimate completion date of March 29, 2024 and a ceiling value of $1,832.99. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The delivery order has a potential value of $10,695.50 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not subject to any set-aside requirements. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,521.95 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of COSENTYX SENSOREADY 150 MG PEN medication. This delivery order has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously been awarded an indefinite delivery contract (IDC) by DLA with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceuticals. The award, valued at $15,219.50, has a completion date of May 1, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,820.90 firm fixed-price contract is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The delivery order has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SENSOREADY 150 MG PENML. The delivery order is worth $27,227.39 and is a firm fixed-price contract with a completion date of December 12, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $18,694.84 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products, with a completion date of February 5, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, COSENTYX UNOREADY 300 MG PEN 2ML. The $1,521.95 firm fixed-price contract has a completion date of May 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen with DLA Troop Support Medical, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a $7,660.53 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order falls under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,486.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance ending on March 13, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA8G7Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of COSENTYX SENSOREADY 150 MG PEN ML pharmaceutical products. The $3,043.90 delivery order has an ultimate completion date of March 21, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order awarded is a task order issued under this IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 3/20/24 |